α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-3-O-(1-oxohexadecyl)-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl- (9CI),254449-38-2-Amadis Chemical-Amadis Chemical

Accueil > Catalogue de produits > sciences de la vie > nucléoside > α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-3-O-(1-oxohexadecyl)-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl- (9CI)

[CAS No.254449-38-2] A1255359 α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-3-O-(1-oxohexadecyl)-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl- (9CI) 97%

Rechercher après modification

Numéro de catalogue: A1255359

Cas No.: 254449-38-2

Formule moléculaire: C₄₀H₆₃N₅O₁₃

Masse moléculaire: 821.95

MDL No:

EINECS:

Commande/demande de devis/Support technique

Téléphone: 0086-571-89925085
passer commande & demande de renseignements: sales@amadischem.com
support technique: tech@amadischem.com

Demande groupée

*Tous les produits chimiques de notre société sont réservés à un usage en laboratoire et à des fins de fabrication.

contrôle qualité [254449-38-2]

NMR

CNMR

HPLC

LC-MS

documents connexes [254449-38-2]

SDS

Specification

MOL

SDF

Informations de base [254449-38-2]

Synonymes: α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-3-O-(1-oxohexadecyl)-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl- (9CI)

Aspect:

Point de fusion:

Point d’ébullition:

Point d'éclair:

Conditions de stockage: Store in 2-8°C for long term (months)

Pubchem ID:

Smiles: [C@H](O[C@H]1OC(C(N[C@@H]2C(=O)N[C@H](C)CCC2)=O)=C[C@H](OC(CCCCCCCCCCCCCCC)=O)[C@@H]1O)(C(N)=O)[C@@]3([C@@H](OC)[C@@H](O)[C@@H](O3)N4C(=O)NC(=O)C=C4)[H]

Inchi: InChI=1S/C40H63N5O13/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-20-29(47)55-26-23-27(37(52)43-25-19-17-18-24(2)42-36(25)51)56-39(30(26)48)58-34(35(41)50)33-32(54-3)31(49)38(57-33)45-22-21-28(46)44-40(45)53/h21-26,30-34,38-39,48-49H,4-20H2,1-3H3,(H2,41,50)(H,42,51)(H,43,52)(H,44,46,53)/t24-,25+,26+,30+,31-,32+,33+,34-,38-,39-/m1/s1

InchiKey: VVBDJSMUFRFMKE-MRGNPTDUSA-N

Informations de sécurité [254449-38-2]

Pictogramme:

Mot de signalement: Warning

UN No.:

Catégorie de danger:

Classe d'emballage:

Mentions de danger: H302;H315;H319;H332;H335

Conseils de prudence: P261;P280;P305+P351+P338

Littérature associée [254449-38-2]

Désolé, aucune littérature correspondante

Produits similaires [254449-38-2]

A1255462 360772-37-8

α-L-Talofuranuronamide, 1-deoxy-5-O-[2,3-di-O-benzoyl-4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, 2-benzoate (9CI)

Reason:nucléoside

A1255465 327984-00-9

α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-(1-ethylpentyl)-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl- (9CI)

Reason:nucléoside

A1255443 254449-80-4

α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-3-O-[(dodecyloxy)carbonyl]-N-[(3S)-hexahydro-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl- (9CI)

Reason:nucléoside

A1255444 254449-75-7

α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-3-O-[(heptyloxy)carbonyl]-N-[(3S)-hexahydro-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl- (9CI)

Reason:nucléoside

A1255445 254449-66-6

α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-3-O-[(dodecyloxy)carbonyl]-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl- (9CI)

Reason:nucléoside

A1255446 254449-55-3

α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-3-O-[(heptyloxy)carbonyl]-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl- (9CI)

Reason:nucléoside

A1255408 1198073-25-4

α-L-Talofuranuronamide, 1-deoxy-5-O-[(6S)-4,5-di-O-acetyl-3-deoxy-D-erythro-hex-2-enodialdo-6,2-pyranosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, 2-acetate (ACI)

Reason:nucléoside

A1255391 1158951-70-2

α-L-Talofuranuronamide, 1-deoxy-5-O-[2,3-di-O-acetyl-4-deoxy-N-[(3S)-hexahydro-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, 2-acetate (ACI)

Reason:nucléoside

A1255370 613244-97-6

α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-[(3S)-hexahydro-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, 2-heptadecanoate (9CI)

Reason:nucléoside

A1255376 360772-39-0

α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-2,3-O-(1-methylethylidene)-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, 2-(2,2-dimethyldodecanoate) (9CI)

Reason:nucléoside

Détails du produit [254449-38-2]

Désolé, aucun détail sur le produit

Historique de navigation